SMTL ID : 7jyr.1

hALK in complex with 1-[(1R,2R)-1-(2,4-difluorophenyl)-2-[2-(5-methyl-1H-pyrazol-3-yl)-4-(trifluoromethyl)phenoxy]cyclopropyl]methanamine

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.32 Å

Oligo State

monomer

Ligands

1 x VTA: 4-{[(1R,2R)-2-(2,4-difluorophenyl)cyclopropyl]oxy}-3-(5-methyl-1H-pyrazol-3-yl)benzonitrile(Non-covalent)

VTA.1: 18 residues within 4Å: Chain A: L.38, G.39, H.40, V.46, A.64, L.112, E.113, L.114, M.115, A.116, G.118, D.119, R.169, N.170, C.171, L.172, G.185, D.186 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.38, A:V.46, A:L.112, A:D.119, A:L.172 Hydrogen bonds: A:E.113, A:M.115 Water bridges: A:R.36

2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 7 residues within 4Å: Chain A: I.87, S.88, F.90, N.91, H.92, R.97, C.98 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:S.88, A:F.90, A:R.97, A:C.98 EDO.3: 7 residues within 4Å: Chain A: H.160, F.161, I.162, R.164, A.190, I.193, Y.194 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:I.162, A:R.164

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Fujimori, I. et al., Discovery of Novel and Highly Selective Cyclopropane ALK Inhibitors through a Fragment-Assisted, Structure-Based Drug Design. Acs Omega (2020)

Release Date

2021-01-20

Peptides

ALK tyrosine kinase receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

ALK tyrosine kinase receptor

Related Entries With Identical Sequence